Fonte: Hematology, Transfusion and Cell Therapy. Nome do evento: Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular (HEMO). Unidades: ICB, FCF
Assuntos: INIBIDORES DE ENZIMAS, APOPTOSE, LEUCEMIA MIELOIDE AGUDA
ABNT
JAEG, Carlos et al. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.htct.2022.09.267. Acesso em: 22 ago. 2024. , 2022APA
Jaeg, C., Almeida, L. C., Lima, K., Tavares, M. T., Waitman, K. B., Costa-Lotufo, L. V., et al. (2022). A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells. Hematology, Transfusion and Cell Therapy. Amsterdam: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/j.htct.2022.09.267NLM
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267Vancouver
Jaeg C, Almeida LC, Lima K, Tavares MT, Waitman KB, Costa-Lotufo LV, Parise Filho R, Machado Neto JA. A novel HDAC inhibitor potentiates Venetoclax-induced apoptosis in acute myeloid leukemia cells [Internet]. Hematology, Transfusion and Cell Therapy. 2022 ; 44 s158-s159.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.htct.2022.09.267